Appsilon, founded in 2013, delivers open-source R and Python solutions for life sciences organisations navigating regulated environments. The company specialises in deploying validated Statistical Computing Environments on cloud-native platforms and managing large-scale SAS-to-R migrations, enabling faster data-driven decision-making across drug development workflows.
Eight of the ten largest pharmaceutical companies rely on Appsilon's services, including Merck, Johnson & Johnson, and Genmab. The company is a Posit Full Service Certified Partner and a recognised contributor to the open-source community, combining proprietary expertise in R package validation with deep knowledge of clinical data applications and cloud infrastructure.
Named one of Europe's fastest-growing companies by The Financial Times 1000 for two consecutive years, Appsilon maintains selective hiring practices, recruiting approximately one per cent of its 15,000+ annual applicants. The company emphasises software excellence and validated statistical computing in regulated settings, positioning itself at the intersection of open-source innovation and enterprise pharmaceutical infrastructure.